E: Strategic considerations for enhanced patient involvement in HTAs

2025 presents the EU with an impending transformation — the implementation of the JCA process across all 27 member states. This harmonisation offers a remarkable opportunity to integrate patients and patient organisations into the JCA framework, not just as participants but as active collaborators in healthcare decision-making.

To leverage this opportunity to optimise patient engagement effectively, three key areas call for strategic consideration:

1. Empowering patients through education and resources:
   • Comprehensive training programs: Develop tailored educational initiatives to demystify the HTA process for patients.
   • Interactive workshops: Organise hands-on sessions to equip patients with the skills to contribute effectively.
2. Forging early collaborations with patients in product development:
   • Uncovering real-world needs: Involve patients at the earliest stages of product development to gain invaluable insights into their experiences and steer innovation accordingly.
   • Shaping value propositions: Align product profiles with patient preferences to address unmet patient needs and create compelling value propositions.
3. Ensuring transparency, impact and clarifying the role of patient voices:
   • Establishing funding mechanisms: Offer compensation for patient contributions to foster equitable involvement and mitigate financial barriers.
   • Communicating clearly: Articulate how patient input will be utilised and its influence on outcomes to build trust and ensure meaningful participation.
   • Implementing feedback loops: Create channels for patients to voice their perspectives on the process and its efficacy to drive continuous improvement.

By addressing these strategic considerations, healthcare stakeholders can foster meaningful patient involvement in HTAs, leading to more patient-centric healthcare decisions, improved outcomes, and a healthcare system that truly reflects the needs and values of the patients it serves.

As the EU moves towards the standardisation of the JCA process, it is crucial to ensure that patients and patient organisations are actively involved as co-architects of healthcare decision-making. Valid Insight stands ready to be your partner in navigating market access and patient engagement within the HTA and JCA processes.